JPG PDF PNG ? zip

Composites in Manufacturing Magazine

  • Articles
    • News
    • Features
    • Products
  • Video
  • Magazine
    • Digital Editions
    • Subcontractor sourcing guide
    • Latest Newsletter
    • Editorial Programme
  • Literature
  • Events
  • Associations
  • Subscribe
  • Advertising
    • Readership
    • Editorial Programme
    • Digital/eMarketing
    • Rates & Specs
    • Media Pack 2021
    • Members’ Directory
    • Members’ Directory Brochure
  • Contact Us

Solvay’s Xencor LFT targets structural medical equipment parts

14 February 2020 • In Products
Solvay’s Xencor LFT targets structural medical equipment parts

Solvay’s Xencor LFT compounds deliver high strength and enhanced impact resistance for structural applications.

These long glass fibre-reinforced thermoplastics (LFT) offer healthcare designers and OEMs new opportunities to replace metal and traditional short fibre thermoplastics used in structural medical components. Typical applications include chassis, gear systems and components needing high mechanical properties and load-bearing capabilities. Solvay is showcasing these new materials at MD&M West 2020 in booth #2414.

Solvay’s pultrusion manufacturing process produces continuous and highly aligned glass fibre-reinforced Xencor LFT compounds that provide better retention of mechanical properties at elevated temperatures along with very low creep, outstanding fatigue resistance and excellent surface finish. Depending on the polymer and grade, Xencor LFT compounds can contain between 30 to 60 percent long fibre reinforcement.

The advantages of using Xencor LFT compounds over metals include lighter weight, expanded design freedom, superior chemical resistance and streamlined processing. These benefits were recently demonstrated with the development of the first all-polymer e-bike from Stavjelo for which certain technical requirements can be applied to medical equipment.

“Xencor LFT compounds enhance our already robust metal-to-plastic replacement product portfolio for medical equipment,’’ said Jeff Hrivnak, global business manager for Healthcare at Solvay Specialty Polymers global business unit. “As is typical with our portfolio, Xencor LFT products stand up to aggressive disinfectants needed in healthcare and can reduce overall manufacturing costs through the use of high-speed injection moulding.’’

The Xencor LFT portfolio is comprised of grades based on select Solvay semi-crystalline resin systems: Ryton polyphenylene sulfide (PPS), Amodel polyphthalamide (PPA) and Ixef polyarylamide (PARA).

www.solvayspecialtypolymers.com

Mike Richardson

Tags

Solvay long glass fibre-reinforced thermoplastics (LFT) medical sector

Share This Article

Tweet

Share

Share

Share

Subscribe to our FREE Newsletter

Related Articles

Solvay and Vertical Aerospace partner on electric air-taxi programme

2 months ago Mike Richardson
news

Solvay and Leonardo launch joint research lab for thermoplastic composites

3 months ago Mike Richardson
news

Solvay has received a binding offer from Composites One

5 months ago Michael Tyrrell
news

Most recent Articles

Quantum key distribution trial takes place at NCC

19 hours ago Michael Tyrrell
news

Sicomin launches fire retardant bio-epoxy laminating resin

2 days ago Michael Tyrrell
news

New composites application for furniture and interiors

2 days ago Michael Tyrrell
news

Share This Article

Tweet

Share

Share

Share

Subscribe to our FREE Newsletter

February/March 2021

Subscribe to our FREE Media Network

INFORMATION

    • About Us
    • Privacy
    • Cookie Policy
    • Contact Us

CATEGORIES

  • Features (635)
  • Literature (13)
  • News (2,499)
  • Products (102)
  • Video (71)

TAGS

  • Continuing Professional Development (CPD)
  • smoothing
  • digital manufacturing
  • multimaterials
  • satellite

OUR OTHER MAGAZINES

Aerospace Manufacturing Logo Composites in Manufacturing Logo

CONTACT INFORMATION

  • Composites in Manufacturing Magazine
  • MIT Publishing
  • Featherstone House
  • 375 High Street
  • Rochester
  • Kent
  • ME1 1DA
01634 830566

Back To Top

1998 - 2021 © MIT Publishing
Site designed & developed by TJC